How does eye cancer treatment affect daily life? new study aims to find out
NCT ID NCT07421739
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tracks how choroidal melanoma and its treatment affect patients' quality of life. It involves 15 people already in a larger Phase 3 trial. Participants fill out questionnaires about their well-being over two years. No new drugs or procedures are tested here.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOROIDAL MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Eye Research Australia
RECRUITINGEast Melbourne, Victoria, 3002, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Supercharged immune cells take aim at childhood cancers
- Can a vaccine keep melanoma from coming back? large trial tests immune boosters
- Can a pill prevent eye cancer spread? new trial aims to find out
- New proton therapy aims to save eyes from removal in large melanoma cases
- Researchers track Long-Term safety of experimental eye cancer drug
- New drug shows promise in shrinking eye cancer before surgery